Dr. Jinal Patel, Cornell university, United States.
Dr. Jinal Patel is a passionate biochemical scientist with a diverse international background, spanning New Zealand, India, and the USA. Her expertise lies in applied and translational research, with a focus on molecular biology, protein biochemistry, and diagnostic technology. Dr. Patel’s career includes roles in both academic and clinical settings, where she has honed her skills in techniques like protein crystallography, enzyme inhibition, and biosensor development. A team player and mentor, she thrives on collaboration and is motivated by the potential of her work to impact scientific research and healthcare. 
Publication profile
Education
- Ph.D. in Chemistry, The University of Auckland (2017–2020)
- Diploma in Business Management, Royal Business College, Auckland (2015–2016)
- M.Sc. in Biochemistry, Veer Narmad South Gujarat University (2010–2012)
- Post Graduate Diploma in Medical Laboratory Technology, Veer Narmad South Gujarat University (2009–2010)
- B.Sc. in Microbiology, Veer Narmad South Gujarat University (2006–2009)
Experience
Postdoctoral Research Associate, Baker Institute of Animal Health, Ithaca, NY (Jan 2024–Present)
Postdoctoral Research Associate, Rensselaer Polytechnic Institute, Troy, NY (Jan 2022–Dec 2023)
Course Developer, The University of Auckland (Jul–Dec 2020)- Laboratory Instrument Demonstrator, The University of Auckland (2018–2020)
Scientific Officer, Desai Metropolis Laboratory, Surat, India (2012–2014)
Suitability For The Award
Dr. Jinal Patel is an exceptionally qualified scientist with a wealth of experience and expertise in applied and translational biochemical research. Her work spans multiple countries, including India, New Zealand, and the USA, where she has made significant contributions in molecular biology, protein research, and enzyme technology. Dr. Patel’s academic achievements, combined with her practical applications in research, make her a strong candidate for the Women Researcher Award.
Professional Development
Dr. Patel is dedicated to continuous learning and professional growth. She has developed and implemented laboratory courses, participated in high-level research, and conducted outreach to educate future scientists. Her work involves close collaboration with industry partners on diagnostics and point-of-care testing technologies. As a mentor, she provides guidance to graduate students and continually develops her skills in cutting-edge research techniques, such as protein design and biophysical methods. With a background in both science and business, she brings a well-rounded perspective to her research, aiming to make impactful contributions in the field. 
Research Focus
Awards and Honors
Graduated with First Class Honors in B.Sc., Veer Narmad South Gujarat University
Consistently ranked in the top 10% throughout her undergraduate studies
Recognized for excellence in lab course development at The University of Auckland
Publications
- “Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topotecan on in vivo tumor models” – AL Zakharenko, OA Luzina, DN Sokolov, VI Kaledin, VP Nikolin, … European Journal of Medicinal Chemistry 161, 581-593, 74 citations, 2019
- “New hydrazinothiazole derivatives of usnic acid as potent Tdp1 inhibitors” – AS Filimonov, AA Chepanova, OA Luzina, AL Zakharenko, OD Zakharova, … Molecules 24 (20), 3711, 47 citations, 2019
- “Promising new inhibitors of tyrosyl-DNA phosphodiesterase I (Tdp 1) combining 4-arylcoumarin and monoterpenoid moieties as components of complex antitumor therapy” – TM Khomenko, AL Zakharenko, AA Chepanova, ES Ilina, OD Zakharova, … International Journal of Molecular Sciences 21 (1), 126, 45 citations, 2019
- “A Novel Class of Tyrosyl-DNA Phosphodiesterase 1 Inhibitors That Contains the Octahydro-2H-chromen-4-ol Scaffold” – NS Li-Zhulanov, AL Zakharenko, AA Chepanova, J Patel, A Zafar, … Molecules 23 (10), 2468, 40 citations, 2018
- “The development of Tyrosyl-DNA phosphodiesterase 1 inhibitors. Combination of monoterpene and adamantine moieties via amide or thioamide bridges” – AA Chepanova, ES Mozhaitsev, AA Munkuev, EV Suslov, DV Korchagina, … Applied Sciences 9 (13), 2767, 32 citations, 2019
- “Novel inhibitors of DNA repair enzyme TDP1 combining monoterpenoid and adamantane fragments” – ES Mozhaitsev, AL Zakharenko, EV Suslov, DV Korchagina, … Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry), 27 citations, 2019
